Annual EBITDA
-$397.33 M
-$1.89 B-126.65%
December 31, 2024
Summary
- As of March 14, 2025, BNTX annual EBITDA is -$397.33 million, with the most recent change of -$1.89 billion (-126.65%) on December 31, 2024.
- During the last 3 years, BNTX annual EBITDA has fallen by -$18.15 billion (-102.24%).
- BNTX annual EBITDA is now -102.24% below its all-time high of $17.75 billion, reached on December 31, 2021.
Performance
BNTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$495.03 M
+$262.86 M+113.22%
December 31, 2024
Summary
- As of March 14, 2025, BNTX quarterly EBITDA is $495.03 million, with the most recent change of +$262.86 million (+113.22%) on December 31, 2024.
- Over the past year, BNTX quarterly EBITDA has increased by +$262.86 million (+113.22%).
- BNTX quarterly EBITDA is now -91.04% below its all-time high of $5.53 billion, reached on September 30, 2021.
Performance
BNTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$392.55 M
-$307.70 M-362.64%
December 31, 2024
Summary
- As of March 14, 2025, BNTX TTM EBITDA is -$392.55 million, with the most recent change of -$307.70 million (-362.64%) on December 31, 2024.
- Over the past year, BNTX TTM EBITDA has dropped by -$307.70 million (-362.64%).
- BNTX TTM EBITDA is now -101.87% below its all-time high of $20.98 billion, reached on March 31, 2022.
Performance
BNTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BNTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -126.7% | +113.2% | -362.6% |
| 3 y3 years | -102.2% | +113.2% | -362.6% |
| 5 y5 years | -146.8% | +313.6% | +7.4% |
BNTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -102.2% | at low | -90.7% | +161.4% | -101.9% | at low |
| 5 y | 5-year | -102.2% | at low | -91.0% | +161.4% | -101.9% | +7.4% |
| alltime | all time | -102.2% | at low | -91.0% | +161.4% | -101.9% | +7.4% |
BioNTech SE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$397.33 M(-126.6%) | $495.03 M(+113.2%) | -$392.55 M(+362.6%) |
| Sep 2024 | - | $232.17 M(-128.8%) | -$84.85 M(+280.7%) |
| Jun 2024 | - | -$806.06 M(+157.0%) | -$22.29 M(-106.0%) |
| Mar 2024 | - | -$313.69 M(-139.1%) | $370.49 M(-75.5%) |
| Dec 2023 | $1.49 B(-89.2%) | $802.73 M(+172.4%) | $1.51 B(-62.1%) |
| Sep 2023 | - | $294.73 M(-171.3%) | $3.98 B(-35.6%) |
| Jun 2023 | - | -$413.28 M(-150.1%) | $6.19 B(-28.7%) |
| Mar 2023 | - | $824.97 M(-74.8%) | $8.68 B(-34.0%) |
| Dec 2022 | $13.81 B(-22.2%) | $3.28 B(+31.0%) | $13.16 B(-13.2%) |
| Sep 2022 | - | $2.50 B(+20.0%) | $15.16 B(-16.6%) |
| Jun 2022 | - | $2.08 B(-60.7%) | $18.19 B(-13.3%) |
| Mar 2022 | - | $5.30 B(+0.3%) | $20.98 B(+18.7%) |
| Dec 2021 | $17.75 B | $5.28 B(-4.4%) | $17.67 B(+39.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $5.53 B(+13.5%) | $12.65 B(+83.6%) |
| Jun 2021 | - | $4.87 B(+144.0%) | $6.89 B(+256.2%) |
| Mar 2021 | - | $2.00 B(+665.3%) | $1.94 B(-1868.1%) |
| Dec 2020 | -$120.03 M(-25.4%) | $260.76 M(-212.5%) | -$109.44 M(-74.2%) |
| Sep 2020 | - | -$231.78 M(+159.2%) | -$423.89 M(+96.6%) |
| Jun 2020 | - | -$89.43 M(+82.5%) | -$215.56 M(+26.8%) |
| Mar 2020 | - | -$49.00 M(-8.7%) | -$169.98 M(+7.2%) |
| Dec 2019 | -$160.98 M(+469.1%) | -$53.69 M(+129.0%) | -$158.55 M(+64.0%) |
| Sep 2019 | - | -$23.45 M(-46.5%) | -$96.67 M(+4.9%) |
| Jun 2019 | - | -$43.85 M(+16.7%) | -$92.18 M(+90.7%) |
| Mar 2019 | - | -$37.57 M(-558.5%) | -$48.33 M(+349.0%) |
| Dec 2018 | -$28.29 M(-66.6%) | $8.19 M(-143.2%) | -$10.76 M(-43.2%) |
| Sep 2018 | - | -$18.96 M | -$18.96 M |
| Dec 2017 | -$84.60 M | - | - |
FAQ
- What is BioNTech SE annual EBITDA?
- What is the all time high annual EBITDA for BioNTech SE?
- What is BioNTech SE annual EBITDA year-on-year change?
- What is BioNTech SE quarterly EBITDA?
- What is the all time high quarterly EBITDA for BioNTech SE?
- What is BioNTech SE quarterly EBITDA year-on-year change?
- What is BioNTech SE TTM EBITDA?
- What is the all time high TTM EBITDA for BioNTech SE?
- What is BioNTech SE TTM EBITDA year-on-year change?
What is BioNTech SE annual EBITDA?
The current annual EBITDA of BNTX is -$397.33 M
What is the all time high annual EBITDA for BioNTech SE?
BioNTech SE all-time high annual EBITDA is $17.75 B
What is BioNTech SE annual EBITDA year-on-year change?
Over the past year, BNTX annual EBITDA has changed by -$1.89 B (-126.65%)
What is BioNTech SE quarterly EBITDA?
The current quarterly EBITDA of BNTX is $495.03 M
What is the all time high quarterly EBITDA for BioNTech SE?
BioNTech SE all-time high quarterly EBITDA is $5.53 B
What is BioNTech SE quarterly EBITDA year-on-year change?
Over the past year, BNTX quarterly EBITDA has changed by +$262.86 M (+113.22%)
What is BioNTech SE TTM EBITDA?
The current TTM EBITDA of BNTX is -$392.55 M
What is the all time high TTM EBITDA for BioNTech SE?
BioNTech SE all-time high TTM EBITDA is $20.98 B
What is BioNTech SE TTM EBITDA year-on-year change?
Over the past year, BNTX TTM EBITDA has changed by -$307.70 M (-362.64%)